Exhale Wellness launches its new line of Delta 9 Gummies - Bottle Caps. Learn about the product - ingredients, flavors, lab ...

In recent years, the demand for natural remedies has surged, particularly those that address common health concerns like ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

CBD oil's popularity surges across wellness and pharmaceutical sectors, lauded for potential benefits like pain and anxiety relief without psychoactive effects. Derived from hemp, it interacts with ...

It affects our body's nervous system and pain receptors, creating a strong, sedative, and calming effect. This helps people to achieve longer and more restful sleep [3]. Appetite Stimulation ...

This design prevents the molecule from having psychoactive side effects. In mouse studies, VIP36 treated inflammatory pain, nerve pain, and migraines (Nature 2025, DOI: 10.1038/s41586-025-08618-7).

They focused on creating a modified cannabinoid that selectively targets peripheral pain receptors located outside the brain and spinal cord. The researchers also used sophisticated computational ...

CB1 receptors can be found throughout the body and are particularly dense in the brain’s pain circuitry. They have long been considered a potential target for non-opioid-based pain treatment ...

Israeli biotech SciSparc has sold the license for its cannabinoid receptor type 2 (CB2R) agonist to its partner Polyrizon to further develop as a pain therapy. The agreement will see Polyrizon ...

Addition of tetrahydrocannabinol (THC) with or without cannabidiol (CBD) to opioid-based treatment for chronic pain was not consistently shown in current research to provide an analgesic benefit ...